These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 7329898)

  • 1. Hearing Loss in Beta-Thalassemia: Systematic Review.
    Tartaglione I; Carfora R; Brotto D; Barillari MR; Costa G; Perrotta S; Manara R
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA.
    Wonke B; Hoffbrand AV; Aldouri M; Wickens D; Flynn D; Stearns M; Warner P
    Arch Dis Child; 1989 Jan; 64(1):77-82. PubMed ID: 2923478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tinnitus in a patient with beta-thalassaemia intermedia on long-term treatment with desferrioxamine.
    Marsh MN; Holbrook IB; Clark C; Shaffer JL
    Postgrad Med J; 1981 Sep; 57(671):582-4. PubMed ID: 7329898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular changes in patients undergoing long-term desferrioxamine treatment.
    Arden GB; Wonke B; Kennedy C; Huehns ER
    Br J Ophthalmol; 1984 Dec; 68(12):873-7. PubMed ID: 6509007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.
    Kontoghiorghe CN; Kontoghiorghes GJ
    Drug Des Devel Ther; 2016; 10():465-81. PubMed ID: 26893541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yersinia enterocolitis in iron overload.
    Kelly DA; Price E; Jani B; Wright V; Rossiter M; Walker-Smith JA
    J Pediatr Gastroenterol Nutr; 1987; 6(4):643-5. PubMed ID: 3430272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral deferiprone for iron chelation in people with thalassaemia.
    Roberts DJ; Brunskill SJ; Doree C; Williams S; Howard J; Hyde CJ
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004839. PubMed ID: 17636775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial of desferrioxamine entrapped in red cell ghosts.
    Green R; Lamon J; Curran D
    Lancet; 1980 Aug; 2(8190):327-30. PubMed ID: 6105474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term desferrioxamine therapy in thalassemia.
    Modell CB; Beck J
    Ann N Y Acad Sci; 1974; 232(0):201-10. PubMed ID: 4528634
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous subcutaneous administration of deferoxamine in patients with iron overload.
    Propper RD; Cooper B; Rufo RR; Nienhuis AW; Anderson WF; Bunn HF; Rosenthal A; Nathan DG
    N Engl J Med; 1977 Aug; 297(8):418-23. PubMed ID: 882111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography, ultrasound, and cholestatic jaundice.
    Morris A; Fawcitt RA; Wood R; Forbes WS; Isherwood I; Marsh MN
    Gut; 1978 Aug; 19(8):685-8. PubMed ID: 680600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the use of iron-chelating agents for the treatment of iron overload.
    Modell B
    Prog Hematol; 1979; 11():267-312. PubMed ID: 392593
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.